Amgen
Pharma

ESMO: Amgen’s Imdelltra stages Rasonque-like moment in SCLC

When added on top of AstraZeneca’s Imfinzi, Imdelltra reduced the risk of death by 58% as a first-line maintenance therapy in extensive-stage SCLC.
Angus Liu Oct 24, 2026 10:30am
AZ

ESMO: AstraZeneca pitches own Padcev combos in bladder cancer

Oct 24, 2026 10:30am
Metallic arrow symbols illuminated by blue and magenta lights forming a graph on blue and magenta background

Bayer's Nubeqa eyes wider market after phase 3 win

Oct 24, 2026 8:30am
shadow follow leader

Argenx reports Q3 sales bump and a new trial requirement

Oct 23, 2026 11:42am
Texas Texas gavel gavel Texas law Texas court TX Attorney General Texas AG Ken Paxton

Gilead to pay $45M to resolve kickback allegations in Texas

Oct 23, 2026 10:57am
showdown clash versus vs crash lightning fight dispute

The Oral GLP-1 Tracker: Lilly, Novo see script dip amid holiday

Oct 23, 2026 9:51am
More News

GSK's twin FDA wins, Roche's $15B deal and point-of-care ads

Oct 23, 2026 9:28am

COINS Act, Hengrui, Samsung Biologics—Fierce Pharma Asia

Oct 23, 2026 8:42am
Fierce Biotech

Treasury COINS rules add biotech, spares China licensing deals

Oct 22, 2026 11:36pm

Real Chemistry champions health dignity initiative

Oct 22, 2026 8:18pm